InsiderClue
← All stocks

Immunome Inc.

IMNM Net buying
CIK 0001472012 #1696 in the set updated 17 Sep 2026
Bought (12 mo)
$2.31M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$27.51M
$18.48M on a plan · $7.49M straight out of an exercise
Sold at will
$1.54M
4 of 28 sales
Net
−$25.20M
+$766.54K against sales at will

By person

10 insiders · 39 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Barchas Isaac
Director
—
$18.27M (12) scheduled
−$18.27M
92,211
0.0812%
$2.33M
−89.7%
Rosett Max
Chief Financial Officer
—
$2.52M (3) scheduled
−$2.52M
101,287
0.0892%
$2.56M
+410.1%
Lechleider Robert
Chief Medical Officer
—
$2.34M (5) scheduled
−$2.34M
69,805
0.0615%
$1.77M
—
Horn Kinney
CHIEF BUSINESS OFFICER
—
$2.30M (2) scheduled
−$2.30M
0
0.0000%
$0.00
—
SIEGALL CLAY B
President and CEO
$1.75M (4)
—
+$1.75M
870,704
0.7666%
$22.05M
+107.5%
WAGENHEIM PHILIP
Director
—
$1.34M (2)
−$1.34M
341,147
0.3004%
$8.64M
−16.0%
Higgins Jack
Chief Scientific Officer
—
$538.46K (2) scheduled
−$538.46K
60,250
0.0530%
$1.53M
+314.7%
Tsai Philip
Chief Technical Officer
$204.90K (1)
—
+$204.90K
81,550
0.0718%
$2.06M
—
BIENAIME JEAN JACQUES
Director
$351.43K (6)
$203.82K (2)
+$147.61K
43,415
0.0382%
$1.10M
+161.3%
Stoneman Sandra G.
CHIEF LEGAL OFFICER & GC
—
—
—
43,805
0.0386%
$1.11M
+688.6%

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Higgins Jack
11 Sep 2026
Chief Scientific Officer
Sold after exercise
13,200
$25.32
$334.22K
Horn Kinney
4 Aug 2026
CHIEF BUSINESS OFFICER
Sold after exercise
90,616
$25.09
$2.27M
Horn Kinney
7 Jul 2026
CHIEF BUSINESS OFFICER
Sold after exercise
1,092
$25.00
$27.30K
Lechleider Robert
2 Jul 2026
Chief Medical Officer
Sold after exercise
16,072
$23.44
$376.73K
Lechleider Robert
2 Jul 2026
Chief Medical Officer
Sold after exercise
16,214
$22.76
$369.03K
Lechleider Robert
2 Jul 2026
Chief Medical Officer
Sold after exercise
22,714
$21.95
$498.57K
Lechleider Robert
25 Jun 2026
Chief Medical Officer
Sold after exercise
14,420
$20.66
$297.92K
Lechleider Robert
25 Jun 2026
Chief Medical Officer
Sold after exercise
40,580
$19.56
$793.74K
Rosett Max
15 Jun 2026
Chief Financial Officer
Sold after exercise
60,000
$18.23
$1.09M
Rosett Max
2 Apr 2026
Chief Financial Officer
Sold after exercise
1,344
$22.48
$30.21K
Rosett Max
2 Apr 2026
Chief Financial Officer
Sold after exercise
63,656
$21.91
$1.39M
Show all 39 transactions →

What was left out

Form 4 filings counted 37
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 11
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 999,610
History held since 5 Oct 2020